Andrew Mok
Stock Analyst at Barclays
(2.46)
# 2,345
Out of 4,886 analysts
186
Total ratings
54.84%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Equal-Weight | $65 → $45 | $33.05 | +36.16% | 9 | Jul 2, 2025 | |
| AVAH Aveanna Healthcare Holdings | Initiates: Equal-Weight | $5.5 | $4.30 | +27.91% | 1 | Jul 2, 2025 | |
| OSCR Oscar Health | Initiates: Underweight | $17 | $16.81 | +1.13% | 1 | Jul 2, 2025 | |
| HUM Humana | Maintains: Equal-Weight | $273 → $268 | $237.21 | +12.98% | 10 | Jun 12, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $351 → $347 | $232.61 | +49.18% | 7 | Jun 9, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $362 → $350 | $303.71 | +15.24% | 10 | Jun 2, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $171 → $215 | $173.09 | +24.21% | 13 | Jun 2, 2025 | |
| HCA HCA Healthcare | Maintains: Overweight | $366 → $416 | $378.98 | +9.77% | 10 | Jun 2, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $522 → $480 | $346.88 | +38.38% | 8 | Jun 2, 2025 | |
| CVS CVS Health | Maintains: Overweight | $82 → $79 | $66.68 | +18.48% | 9 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $385 | $313.63 | +22.76% | 6 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $25 → $24 | $22.04 | +8.89% | 2 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $23 → $24 | $21.35 | +12.44% | 8 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $35 → $28 | $23.32 | +20.07% | 13 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $3 | $2.33 | +28.76% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $249 → $257 | $181.52 | +41.58% | 22 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $117 → $130 | $119.39 | +8.89% | 16 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $36 | $24.15 | +49.07% | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $60 | $55.26 | +8.58% | 7 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $9 | $13.14 | -31.51% | 4 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $4 | $3.33 | +20.12% | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $164 → $169 | $142.81 | +18.34% | 10 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $111.00 | -25.23% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $7.32 | +63.93% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $96.50 | -1.55% | 7 | Aug 2, 2022 |
Centene
Jul 2, 2025
Maintains: Equal-Weight
Price Target: $65 → $45
Current: $33.05
Upside: +36.16%
Aveanna Healthcare Holdings
Jul 2, 2025
Initiates: Equal-Weight
Price Target: $5.5
Current: $4.30
Upside: +27.91%
Oscar Health
Jul 2, 2025
Initiates: Underweight
Price Target: $17
Current: $16.81
Upside: +1.13%
Humana
Jun 12, 2025
Maintains: Equal-Weight
Price Target: $273 → $268
Current: $237.21
Upside: +12.98%
Molina Healthcare
Jun 9, 2025
Maintains: Equal-Weight
Price Target: $351 → $347
Current: $232.61
Upside: +49.18%
UnitedHealth Group
Jun 2, 2025
Maintains: Overweight
Price Target: $362 → $350
Current: $303.71
Upside: +15.24%
Tenet Healthcare
Jun 2, 2025
Maintains: Overweight
Price Target: $171 → $215
Current: $173.09
Upside: +24.21%
HCA Healthcare
Jun 2, 2025
Maintains: Overweight
Price Target: $366 → $416
Current: $378.98
Upside: +9.77%
Elevance Health
Jun 2, 2025
Maintains: Overweight
Price Target: $522 → $480
Current: $346.88
Upside: +38.38%
CVS Health
Jun 2, 2025
Maintains: Overweight
Price Target: $82 → $79
Current: $66.68
Upside: +18.48%
Jun 2, 2025
Maintains: Overweight
Price Target: $382 → $385
Current: $313.63
Upside: +22.76%
May 27, 2025
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $22.04
Upside: +8.89%
May 27, 2025
Maintains: Equal-Weight
Price Target: $23 → $24
Current: $21.35
Upside: +12.44%
May 14, 2025
Maintains: Equal-Weight
Price Target: $35 → $28
Current: $23.32
Upside: +20.07%
May 8, 2025
Maintains: Underweight
Price Target: $2 → $3
Current: $2.33
Upside: +28.76%
Apr 29, 2025
Maintains: Overweight
Price Target: $249 → $257
Current: $181.52
Upside: +41.58%
Apr 28, 2025
Maintains: Buy
Price Target: $117 → $130
Current: $119.39
Upside: +8.89%
Apr 1, 2025
Initiates: Equal-Weight
Price Target: $36
Current: $24.15
Upside: +49.07%
Mar 24, 2025
Maintains: Overweight
Price Target: $74 → $60
Current: $55.26
Upside: +8.58%
Feb 28, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $13.14
Upside: -31.51%
Feb 20, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $3.33
Upside: +20.12%
Feb 18, 2025
Maintains: Equal-Weight
Price Target: $164 → $169
Current: $142.81
Upside: +18.34%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $111.00
Upside: -25.23%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $7.32
Upside: +63.93%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $96.50
Upside: -1.55%